Dolinnov

1 known investors

Dolinnov is a biotech company developing precision pump modulators (PPMs), a novel class of non-opioid medicines targeting FXYD2 to treat chronic pain. The company uses lipid antisense oligonucleotide (L-ASO) therapy to address neuropathic and inflammatory pain in indications including cancer pain and rare pain-associated disorders.

Biotech